Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Primidone BE study for USFDA submission [Regulatives / Guidelines]

posted by jag009 – NJ, 2018-04-09 18:16 (3002 d 14:47 ago) – Posting: # 18656
Views: 5,433

Haven't looked up the drug but are both metabolites active? To be on the safe side (if you don't want to file control correspondence) then i would measure the active metabolites since FDA usually ask to have the data collected.

John

Complete thread:

Primidone BE study for USFDA submission Ramesh Ramalingam 2018-04-09 05:54
- Primidone BE study for USFDA submissionjag009 2018-04-09 16:16
  - Primidone BE study for USFDA submission bebac_fan 2018-04-10 01:11
    - Primidone BE study for USFDA submission Ramesh Ramalingam 2018-04-11 06:07
  - Primidone BE study for USFDA submission Ramesh Ramalingam 2018-04-11 06:05
- Primidone BE study for USFDA submission balakotu 2018-04-12 15:01

Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
269 visitors (0 registered, 269 guests [including 15 identified bots]).
Forum time: 09:04 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas. Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz